.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Vlasic Labs has shown varying performance across different categories and states, with notable achievements and areas needing improvement. In Michigan, the brand has maintained a strong presence in the Tincture & Sublingual category, consistently ranking 3rd from October 2024 to January 2025, despite a gradual decline in sales from $52,759 in October to $39,591 in January. Meanwhile, their performance in the Edible category is less impressive, as they did not rank in the top 30 in November and January, indicating a potential area for growth. The Topical category in Michigan shows a slight decline in January, retaining the 4th position, suggesting a need for strategic adjustments to maintain competitiveness.
In Missouri, Vlasic Labs is performing exceptionally well in the Tincture & Sublingual category, consistently holding the 2nd position over the same period. This stability is a promising indicator of their strong market presence. However, the Topical category in Missouri shows an upward trend in rankings, improving from 6th in October to 4th by December and maintaining this position in January, reflecting a positive reception and increased market penetration. Conversely, in Nevada, their performance in the Flower category fluctuates, with rankings ranging from 71st to 59th, ultimately dropping back to 65th in January, highlighting a challenging competitive landscape.
Competitive Landscape
In the Missouri Tincture & Sublingual category, Vlasic Labs consistently maintained its position as the second-ranked brand from October 2024 through January 2025, demonstrating a stable market presence despite fluctuations in monthly sales. This stability is particularly noteworthy when compared to Zen Cannabis, which held the third rank during the same period but experienced a downward trend in sales, indicating potential challenges in maintaining consumer interest. Meanwhile, Cannabis Inc emerged in the rankings starting December 2024, securing the fourth position, which suggests a growing competitive pressure. This competitive landscape highlights the importance for Vlasic Labs to continue innovating and engaging with consumers to sustain its market position and potentially capture the top spot.
Notable Products
In January 2025, the CBD Broad Spectrum Tincture (3000mg CBD, 30ml, 1oz) maintained its top position as the leading product for Vlasic Labs, despite a decline in sales to 929 units. The CBN Isolate Tincture (1200mg CBN, 30ml, 1oz) rose to second place, showing a consistent increase in sales over the past months. The CBD Full Spectrum Relief Cream (3000mg CBD, 3oz) dropped to third, reflecting a decrease in demand from December 2024. The CBG Isolate Focus Tincture (1800mg CBG, 30ml, 1oz) moved up to fourth place, while the CBD/CBG 1:1 Restore Citrus & Bergamot Bath Bomb (100mg CBD, 100mg CBG) re-entered the top five. Overall, the Tincture & Sublingual category continues to dominate the rankings for Vlasic Labs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
